33.93
price down icon2.50%   -0.87
after-market Handel nachbörslich: 34.02 0.09 +0.27%
loading

Viking Therapeutics Inc Aktie (VKTX) Neueste Nachrichten

pulisher
05:45 AM

Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts - Yahoo Finance Australia

05:45 AM
pulisher
01:08 AM

Viking Therapeutics, Inc. (VKTX) Latest Stock News & Headlines - Yahoo Finance

01:08 AM
pulisher
10:49 AM

Viking Therapeutics, Inc. (VKTX) Shares Fall as Broader Market Rises: Important Details - Bitget

10:49 AM
pulisher
03:56 AM

Viking Therapeutics Inc (1VT.HM) Interactive Stock Chart - Yahoo! Finance Canada

03:56 AM
pulisher
Apr 05, 2026

Viking Therapeutics, Inc. (VKTX) latest stock news and headlines - Yahoo Finance Singapore

Apr 05, 2026
pulisher
Apr 04, 2026

Viking Therapeutics, Inc. (VKTX) interactive stock chart - Yahoo Finance Singapore

Apr 04, 2026
pulisher
Apr 04, 2026

Viking Therapeutics, Inc. (VKTX) stock price, news, quote and history - Yahoo Finance Singapore

Apr 04, 2026
pulisher
Apr 03, 2026

Where Will Viking Therapeutics Stock Be in 10 Years? - The Globe and Mail

Apr 03, 2026
pulisher
Apr 03, 2026

Where Will Viking Therapeutics Stock Be in 10 Years? - The Motley Fool

Apr 03, 2026
pulisher
Apr 03, 2026

Did VK2735’s VANQUISH-2 Enrollment Milestone Just Reframe Viking Therapeutics' (VKTX) Obesity Drug Ambitions? - Yahoo Finance

Apr 03, 2026
pulisher
Apr 03, 2026

VKTX Stock Rises After-Hours: CNBC Flags Viking As Likely Buyout Target This Year As Big Pharma Hunts Next GLP-1 Winner - stocktwits.com

Apr 03, 2026
pulisher
Apr 02, 2026

Viking Therapeutics (VKTX) stock has failed to impress since Jim Cramer expressed caution - MSN

Apr 02, 2026
pulisher
Apr 02, 2026

VKTX Forecast, Price Target & Analyst Ratings | VIKING THERAPEUTICS INC (NASDAQ:VKTX) - ChartMill

Apr 02, 2026
pulisher
Apr 02, 2026

Viking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

How (VKTX) Movements Inform Risk Allocation Models - Stock Traders Daily

Apr 02, 2026
pulisher
Apr 02, 2026

Here's How Much $100 Invested In Viking Therapeutics 10 Years Ago Would Be Worth Today - Sahm

Apr 02, 2026
pulisher
Apr 01, 2026

[ARS] Viking Therapeutics, Inc. SEC Filing - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

[DEF 14A] Viking Therapeutics, Inc. Definitive Proxy Statement - Stock Titan

Apr 01, 2026
pulisher
Apr 01, 2026

Viking Therapeutics, Inc. (VKTX) declines more than market: Some information for investors - MSN

Apr 01, 2026
pulisher
Apr 01, 2026

43,152 Shares in Viking Therapeutics, Inc. $VKTX Purchased by Royal Fund Management LLC - MarketBeat

Apr 01, 2026
pulisher
Mar 31, 2026

2 Healthcare Stocks Wall Street Analysts Say Could Rally 60% or More - AOL.com

Mar 31, 2026
pulisher
Mar 31, 2026

A Look At Viking Therapeutics (VKTX) Valuation As VANQUISH 2 Enrollment Milestone Advances VK2735 Program - Sahm

Mar 31, 2026
pulisher
Mar 30, 2026

Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors - Yahoo Finance Singapore

Mar 30, 2026
pulisher
Mar 30, 2026

VKTX stock jumps as retail traders pile into obesity pipeline bets - MSN

Mar 30, 2026
pulisher
Mar 30, 2026

The Bull Case For Viking Therapeutics (VKTX) Could Change Following Full VK2735 Phase 3 Enrollment Progress - Sahm

Mar 30, 2026
pulisher
Mar 30, 2026

Viking Therapeutics (VKTX) Stock Has Failed To Impress Since Jim Cramer Expressed Caution - Insider Monkey

Mar 30, 2026
pulisher
Mar 30, 2026

Viking Therapeutics, Inc. (VKTX) Falls Further Than the Overall Market: What Investors Should Know - Bitget

Mar 30, 2026
pulisher
Mar 30, 2026

Viking Therapeutics Approaches Make-or-Break Moment as Key GLP-1 Data Looms - NAI500

Mar 30, 2026
pulisher
Mar 29, 2026

Viking Therapeutics moves closer to challenging Ozempic with phase 3 trial progress - MSN

Mar 29, 2026
pulisher
Mar 29, 2026

Viking Therapeutics: A Small Biotech Firm Competing in the $100B GLP-1 MarketNews and Statistics - indexbox.io

Mar 29, 2026
pulisher
Mar 29, 2026

1 Reason This Biotech Stock Could Triple Before Year-End - Yahoo Finance

Mar 29, 2026
pulisher
Mar 28, 2026

VKTX Stock Jumps As Retail Traders Pile Into Obesity Pipeline Bets - stocktwits.com

Mar 28, 2026
pulisher
Mar 28, 2026

A Look At Viking Therapeutics (VKTX) Valuation As VK2735 Phase 3 Enrollment Reaches Completion - Yahoo Finance

Mar 28, 2026
pulisher
Mar 27, 2026

Viking Therapeutics Inc (VKTX) Stock Price, Quote, News & History - Benzinga

Mar 27, 2026
pulisher
Mar 27, 2026

Viking Therapeutics Trial Milestone Highlights VK2735 And Valuation Gap - simplywall.st

Mar 27, 2026
pulisher
Mar 27, 2026

Vanguard disaggregates holdings; reports 0 shares in Viking (VKTX) - Stock Titan

Mar 27, 2026
pulisher
Mar 27, 2026

VKTX Completes Participant Recruitment for Second Advanced Clinical Trial of Obesity Medication - Bitget

Mar 27, 2026
pulisher
Mar 27, 2026

VKTX Finishes Enrollment in Second Late-Stage Study on Obesity Drug - Yahoo Finance

Mar 27, 2026
pulisher
Mar 27, 2026

Viking Therapeutics completes patient enrolment in VANQUISH-2 trial - Clinical Trials Arena

Mar 27, 2026
pulisher
Mar 27, 2026

Viking Therapeutics completes enrollment in obesity drug trial By Investing.com - Investing.com Australia

Mar 27, 2026
pulisher
Mar 26, 2026

Published on: 2026-03-27 10:35:11 - baoquankhu1.vn

Mar 26, 2026
pulisher
Mar 26, 2026

Better Weight Loss Drug Stock Buy: Eli Lilly vs Viking Therapeutics - AOL.com

Mar 26, 2026
pulisher
Mar 26, 2026

VKTX.O - Reuters

Mar 26, 2026
pulisher
Mar 26, 2026

Viking Therapeutics (NASDAQ:VKTX) Now Covered by Wolfe Research - MarketBeat

Mar 26, 2026
pulisher
Mar 26, 2026

Morgan Stanley reiterates Viking Therapeutics stock rating on trial progress - Investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

Viking Therapeutics Moves Closer To Challenging Ozempic With Phase 3 Trial Progress - Stocktwits

Mar 26, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):